| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,345 |
7,015 |
$301K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,959 |
2,678 |
$147K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
717 |
676 |
$57K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
712 |
701 |
$55K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,211 |
1,099 |
$47K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
618 |
603 |
$46K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,449 |
3,142 |
$45K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,130 |
1,443 |
$40K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
474 |
448 |
$37K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
3,097 |
2,012 |
$36K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
669 |
650 |
$16K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
178 |
172 |
$13K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
476 |
444 |
$13K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
188 |
175 |
$9K |
| 87807 |
|
692 |
637 |
$7K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
110 |
109 |
$6K |
| 90461 |
|
1,415 |
1,303 |
$5K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
584 |
540 |
$4K |
| 87634 |
|
42 |
40 |
$2K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
238 |
194 |
$2K |
| 96160 |
|
830 |
777 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
44 |
39 |
$572.40 |
| 94760 |
|
764 |
664 |
$460.60 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
13 |
12 |
$134.64 |
| 96161 |
|
56 |
55 |
$112.50 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
44 |
39 |
$61.04 |
| A9150 |
Non-prescription drugs |
200 |
190 |
$3.50 |
| 90651 |
|
227 |
223 |
$0.15 |
| 90686 |
|
156 |
154 |
$0.07 |
| 90671 |
|
27 |
27 |
$0.03 |
| 90734 |
|
189 |
182 |
$0.01 |
| 90723 |
|
43 |
42 |
$0.00 |
| 90680 |
|
326 |
319 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
45 |
39 |
$0.00 |
| 90697 |
|
25 |
25 |
$0.00 |
| 90670 |
|
672 |
662 |
$0.00 |
| 90633 |
|
115 |
114 |
$0.00 |
| 90715 |
|
49 |
49 |
$0.00 |
| 90648 |
|
159 |
156 |
$0.00 |
| 90710 |
|
52 |
52 |
$0.00 |
| 99173 |
|
13 |
13 |
$0.00 |